Infection Surveillance Solutions

Global Infection Surveillance Solutions Market to Reach US$2.1 Billion by 2030

The global market for Infection Surveillance Solutions estimated at US$852.9 Million in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2024-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Infection Surveillance Services segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$278.7 Million While China is Forecast to Grow at 17.3% CAGR

The Infection Surveillance Solutions market in the U.S. is estimated at US$278.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$233.8 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.1% and 16.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.6% CAGR.

Global Infection Surveillance Solutions Market - Key Trends & Drivers Summarized

What Are Infection Surveillance Solutions and Why Are They Critical?

Infection surveillance solutions are systems and software used by healthcare facilities to monitor and prevent the occurrence and spread of infections within healthcare settings. These systems collect, analyze, and interpret health data to identify potential infection outbreaks and to ensure timely intervention. Such solutions are crucial for maintaining patient safety, managing antimicrobial resistance, and enhancing the overall quality of healthcare services. They track various indicators, including the types of infections, the points of origin within the facility, and the effectiveness of infection control measures. This ongoing surveillance supports hospitals in adhering to regulatory standards and improving patient outcomes.

How Is Technology Enhancing Infection Control?

Advancements in technology have significantly bolstered the capabilities of infection surveillance solutions. Modern systems integrate electronic health records (EHRs), real-time data monitoring, and advanced analytics to provide comprehensive surveillance capabilities. Artificial intelligence (AI) and machine learning (ML) are increasingly being employed to predict infection risks and outbreak patterns, thereby enabling proactive measures. Additionally, mobile platforms enhance the accessibility of surveillance data, facilitating faster response times and improved coordination among healthcare teams. These technological improvements not only increase the efficiency of data management but also enhance the accuracy of infection tracking and the effectiveness of preventive strategies.

What Impact Does Regulatory Compliance Have on the Adoption of These Systems?

Regulatory compliance is a significant driver for the adoption of infection surveillance solutions. In many regions, health authorities require healthcare facilities to implement robust infection control programs to maintain accreditation and receive funding. For instance, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) both provide guidelines and standards for infection surveillance and control. Compliance with these regulations necessitates the adoption of sophisticated surveillance systems capable of providing detailed and accurate data reporting. As regulatory frameworks around the world tighten and focus more on patient safety and quality of care, healthcare providers are increasingly reliant on these solutions to meet their compliance and care standards.

What Drives Growth in the Infection Surveillance Solutions Market?

The growth in the infection surveillance solutions market is driven by several factors, including increasing healthcare-associated infection rates, technological advancements, and stringent regulatory requirements. The rising prevalence of chronic diseases and subsequent increase in hospital stays have also escalated the risk of healthcare-associated infections, thereby boosting the demand for effective surveillance systems. Technological innovations, such as integration with electronic health records and real-time analytics, have enhanced the efficiency and efficacy of these systems. Additionally, the growing global emphasis on healthcare quality and patient safety, supported by government initiatives and funding for health infrastructure, has propelled the adoption of advanced surveillance solutions

SCOPE OF STUDY:

The report analyzes the Infection Surveillance Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Software, Services); End-Use (Hospitals, Long-Term Care Facilities, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 40 Featured) -

• IBM Corporation
• Becton, Dickinson and Company
• bioMerieux SA
• Illumina, Inc.
• Cerner Corporation
• Ecolab, Inc.
• Gojo Industries, Inc.
• Epic Systems Corporation
• CenTrak, Inc.
• Iatric Systems, Inc.
• Harris Healthcare
• Perahealth, Inc.
• ABILITY Network Inc.
• Asolva, Inc.
• ICNet International

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.